Literature DB >> 25063260

Variability in compounding of oral liquids for pediatric patients: a patient safety concern.

Janis M Rood, Melanie J Engels, Scott L Ciarkowski, Larry D Wagenknecht, Chris J Dickinson, James G Stevenson.   

Abstract

OBJECTIVE: To determine the degree in variation of oral liquid pediatric compounding practices in Michigan pharmacies.
DESIGN: Cross-sectional survey study.
SETTING: All types of inpatient and outpatient pharmacies across the state of Michigan, excluding nuclear pharmacies and long-term care facilities. PARTICIPANTS: 244 Michigan pharmacies. INTERVENTION: An online survey tool was used to assess the current compounding practices of 147 oral liquid pediatric medications. The survey was e-mailed or faxed to hospitals, chain pharmacies, and independent pharmacies. Pharmacists were also mailed a follow-up postcard, and the Michigan Pharmacists Association publicized the project through its journal and annual meeting. MAIN OUTCOME MEASURES: Pharmacy demographics; number of compounding pharmacies; number of medications compounded; awareness of compounding errors; results of compounding errors; and number of concentrations compounded per medication.
RESULTS: The majority of respondents were from outpatient pharmacies, but inpatient and other types of pharmacies were also represented. The majority of participating pharmacies compound fewer than five oral liquid medications per week. Awareness of errors was low overall, with no errors believed to result in permanent harm or death. The number of concentrations compounded per medication ranged from 1 to 9, with the majority of pharmacies compounding more than 3 concentrations per medication.
CONCLUSION: There is a considerable degree of variation in current oral pediatric liquid compounding practices in Michigan pharmacies. This variability poses a significant risk to patient safety.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25063260     DOI: 10.1331/JAPhA.2014.13074

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  3 in total

1.  Trends in Outpatient Prescription Medicine Use in New Zealand Children 2010-2015: A National Population-Based Study.

Authors:  Andrew M Tomlin; David J Woods; Hywel S Lloyd; Murray W Tilyard
Journal:  Paediatr Drugs       Date:  2018-10       Impact factor: 3.022

2.  Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.

Authors:  Hudson C Polonini; Sharlene L Silva; Thalyta R de Almeida; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-03-24

3.  Providing Suitable Pediatric Formulations for Canadian Children: A Call for Action.

Authors:  Catherine Litalien; Julie Autmizguine; Antoine Carli; Denis Giroux; Denis Lebel; Jean-Marie Leclerc; Yves Théorêt; Andrea Gilpin; Sophie Bérubé
Journal:  Can J Hosp Pharm       Date:  2020-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.